Showing results (2921-2930 of 11,196) with videos related to
Sort By:
Pageof 1,120
Journal of Neurology|August 15, 2014
Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-TKatharina Müller, Joseph Kuchling, Jan Dörr, et al.Journal of Neurology|August 15, 2014
The presence of dysautonomia in different subgroups of myasthenia gravis patientsAna Nikolić, Stojan Perić, Tanja Nišić, et al.Journal of Neurology|October 29, 2013
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseasesM C Kowarik, V Grummel, S Wemlinger, et al.Journal of Neurology|October 29, 2013
Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and EuropeCatherine L Bladen, Rachel Thompson, Jacqueline M Jackson, et al.Journal of Neurology|October 29, 2013
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric studyFrançois Mouton-Liger, David Wallon, Anne-Cécile Troussière, et al.Journal of Neurology|August 24, 2014
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide studyDario Cocito, Aristide Merola, Erdita Peci, et al.Journal of Neurology|August 24, 2014
Novel EXOSC3 mutation causes complicated hereditary spastic paraplegiaAyelet Halevy, Israela Lerer, Rony Cohen, et al.Journal of Neurology|September 4, 2014
Screening for dopa-responsive dystonia in patients with Scans Without Evidence of Dopaminergic Deficiency (SWEDD)Anna De Rosa, Claudia Carducci, Carla Carducci, et al.Journal of Neurology|March 3, 2016
Validation of the MG-DIS: a disability assessment for myasthenia gravisAlberto Raggi, Matilde Leonardi, Silvia Schiavolin, et al.Journal of Neurology|March 12, 2016
Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's diseaseElena Lezcano, Juan Carlos Gómez-Esteban, Beatriz Tijero, et al.Pageof 1,120